Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 11/20 | 0.48 |
| ▸ | CA12 | O43570 | 10/20 | 0.48 |
| ▸ | CA1 | P00915 | 10/20 | 0.48 |
| ▸ | CA9 | Q16790 | 10/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8908686 | 0.91 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL13019176 | 0.90 | THRB (0.53) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL10056659 | 0.90 | THRB (0.53) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL12157410 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL10520478 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL14365714 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL1582431 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL21750083 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL21750089 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL13655911 | 0.83 | CYP2D6 (0.66) | CYP2D6THRBHSD17B10CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9206226-B2 | Non-ionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| US-20140302554-A1 | NON-IONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | SUMMIT RESOURCES, INC. | 2014-10-09 | — | — | US | disclosed |
| US-8791251-B2 | Non-ionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2014-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140302554-A1 | NON-IONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | F12, PROC, F11 | CYP2D6 4594/4885THRB 3779/4885HSD17B10 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.